VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 40 filers reported holding VBI VACCINES INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,561 | -93.7% | 21,654 | -91.9% | 0.00% | – |
| Q4 2022 | $104,798 | +63.7% | 267,957 | +195.7% | 0.00% | – |
| Q3 2022 | $64,000 | -19.0% | 90,603 | -7.0% | 0.00% | – |
| Q2 2022 | $79,000 | +41.1% | 97,439 | +190.0% | 0.00% | – |
| Q1 2022 | $56,000 | -86.3% | 33,601 | -80.8% | 0.00% | – |
| Q4 2021 | $410,000 | -72.5% | 174,822 | -63.6% | 0.00% | – |
| Q3 2021 | $1,493,000 | -42.9% | 479,887 | -38.5% | 0.00% | – |
| Q2 2021 | $2,615,000 | +98.6% | 780,466 | +84.4% | 0.00% | – |
| Q1 2021 | $1,317,000 | +79.7% | 423,347 | +58.8% | 0.00% | – |
| Q4 2020 | $733,000 | -43.9% | 266,533 | -41.7% | 0.00% | – |
| Q3 2020 | $1,306,000 | +412.2% | 456,823 | +455.5% | 0.00% | – |
| Q2 2020 | $255,000 | +1600.0% | 82,243 | +157.2% | 0.00% | – |
| Q3 2019 | $15,000 | -91.3% | 31,976 | -78.4% | 0.00% | – |
| Q2 2019 | $173,000 | -47.7% | 148,028 | +23.0% | 0.00% | -100.0% |
| Q2 2018 | $331,000 | – | 120,313 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.16% |
| GENERAL AMERICAN INVESTORS CO INC | 1,827,497 | $5,684,000 | 0.53% |
| Frontier Wealth Management LLC | 636,000 | $1,978,000 | 0.15% |
| Weil Company, Inc. | 56,685 | $176,000 | 0.10% |
| ArchPoint Investors | 80,000 | $249,000 | 0.07% |
| HighVista Strategies LLC | 28,600 | $89,000 | 0.07% |
| FIRST MIDWEST BANK TRUST DIVISION | 150,546 | $468,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 124,118 | $386,000 | 0.06% |
| TCI Wealth Advisors, Inc. | 30,000 | $93,000 | 0.04% |
| DCF Advisers, LLC | 26,000 | $81,000 | 0.04% |